The risk of arterial thromboembolic events with chemotherapy appears to be increased with the addition of bevacizumab [Avastin]

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1492, 2005-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased risk of thromboembolic events with Avastin

By  

Reactions Weekly, Vol. 1, Iss. 1015, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Bevacizumab: increased risk of venous thromboembolism

By  

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Bevacizumab: increased risk of venous thromboembolism

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events

By Yinon Yoav   Pauzner Rachel   Dulitzky Mordechai   Elizur Shai E   Dor Jehoshua   Shulman Adrian  

Reproductive BioMedicine Online, Vol. 12, Iss. 3, 2006-03 ,pp. : 354-358

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Thromboembolic events a risk in off-label use of rFVIIa

By  

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite